Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nordic Spirit is a tobacco-free oral nicotine pouch developed by Nordic Snus AB, a subsidiary of JT International SA. The product is designed as a harm reduction or smoking cessation tool for adult smokers, providing a smoke-free alternative to combustible cigarettes. The pouches are composed of plant-based fibers and a gum base, containing pharmaceutical-grade nicotine and food-grade flavorings. When placed between the upper lip and gum, the pouch delivers nicotine through the oral mucosa into the systemic circulation. The nicotine then acts as an agonist at nicotinic acetylcholine receptors in the brain, mimicking the effects of tobacco-derived nicotine to alleviate cravings and withdrawal symptoms. It is available in various strengths, including 6 mg, 9 mg, and 11.2 mg per pouch.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Nordic Spirit.